Literature DB >> 1768562

Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.

P A Soons1, A De Boer, A F Cohen, D D Breimer.   

Abstract

1. The applicability of a continuous infusion of indocyanine green (ICG) to detect changes in apparent hepatic blood flow (HBF) was investigated in six healthy subjects. 2. High-performance liquid chromatography was used to measure ICG concentrations, and the effect of intravenous propranolol (10 mg in 10 min) on HBF was investigated. 3. During 150 min infusions of ICG (1.0 mg min-1) steady-state was reached within about 30 min and thereafter the plasma dye concentration remained essentially constant until the end of infusion. 4. Blood clearance (CLb) of ICG (15.9 +/- 2.2 ml min-1 kg-1; mean +/- s.d.), calculated as infusion rate/blood dye concentration over three time periods (30-50, 80-100 and 130-150 min) during the 150 min infusion, was not different from that obtained with three 1-min infusions (0.5 mg kg-1) administered at corresponding times of the day (CLb = 14.0 +/- 2.2 ml min-1 kg-1, P = 0.06). 5. The pharmacokinetics of ICG were shown to be linear up to plasma concentrations of at least 3 micrograms ml-1 using variable infusion rates (0.5, 1.0 and 2.0 mg min-1). 6. Propranolol had little effect on ICG concentrations during continuous infusion. The AUC of ICG from the start of propranolol infusion up to 125 min thereafter was increased by 12% +/- 17% (P = 0.21) compared with placebo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1768562      PMCID: PMC1368549     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  33 in total

1.  Estimation of hepatic blood flow in branches of hepatic vessels utilizing a noninvasive, duplex Doppler method.

Authors:  J R Horn; B Zierler; L A Bauer; W Reiss; D E Strandness
Journal:  J Clin Pharmacol       Date:  1990-10       Impact factor: 3.126

2.  Measurement of normal portal venous blood flow by Doppler ultrasound.

Authors:  H S Brown; M Halliwell; M Qamar; A E Read; J M Evans; P N Wells
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

3.  Estimation of hepatic blood flow with indocyanine green.

Authors:  C M LEEVY; C L MENDENHALL; W LESKO; M M HOWARD
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

4.  Measurement of hepatic blood flow.

Authors:  D J Johnson; F Muhlbacher; D W Wilmore
Journal:  J Surg Res       Date:  1985-11       Impact factor: 2.192

Review 5.  Clearance approaches in pharmacology.

Authors:  G R Wilkinson
Journal:  Pharmacol Rev       Date:  1987-03       Impact factor: 25.468

6.  Influence of nifedipine therapy on indocyanine green and oral propranolol pharmacokinetics.

Authors:  L A Bauer; K Murray; J R Horn; K Opheim; J Olsen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  Indocyanine green clearance as a test for hepatic function. Evaluation by dichromatic ear densitometry.

Authors:  C M Leevy; F Smith; J Longueville; G Paumgartner; M M Howard
Journal:  JAMA       Date:  1967-04-17       Impact factor: 56.272

8.  The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.

Authors:  N D Bax; G T Tucker; M S Lennard; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

9.  Indocyanine green elimination in patients with liver disease and in normal subjects.

Authors:  E Burns; D R Triger; G T Tucker; N D Bax
Journal:  Clin Sci (Lond)       Date:  1991-02       Impact factor: 6.124

10.  Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis.

Authors:  R Mastai; J Bosch; J Bruix; M Navasa; D Kravetz; J Rodés
Journal:  Hepatology       Date:  1989-09       Impact factor: 17.425

View more
  10 in total

Review 1.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

Review 2.  Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies.

Authors:  Marcel P H van den Broek; Floris Groenendaal; Antoine C G Egberts; Carin M A Rademaker
Journal:  Clin Pharmacokinet       Date:  2010-05       Impact factor: 6.447

3.  Clinical aspects of indocyanine green pharmacokinetics following portal vein administration.

Authors:  S Nishi; M Shindo; J Abe; A Asada
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

Review 4.  Dose adjustment in patients with liver disease.

Authors:  Fabiola Delcò; Lydia Tchambaz; Raymond Schlienger; Jürgen Drewe; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  Identifying a long standing error in single-bolus determination of the hepatic extraction ratio for indocyanine green.

Authors:  Eugene H Wissler
Journal:  Eur J Appl Physiol       Date:  2010-10-16       Impact factor: 3.078

Review 6.  Effect of hepatic insufficiency on pharmacokinetics and drug dosing.

Authors:  R K Verbeeck; Y Horsmans
Journal:  Pharm World Sci       Date:  1998-10

Review 7.  Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.

Authors:  Roger K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  2008-09-02       Impact factor: 2.953

8.  Assessment of hepatic blood flow using continuous infusion of high clearance drugs.

Authors:  R C Schoemaker; J Burggraaf; A F Cohen
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

9.  Endothelial binding of recombinant tissue plasminogen activator: quantification in vivo using a recirculatory model.

Authors:  Michiel J Kemme; Rik C Schoemaker; Jacobus Burggraaf; Monique van der Linden; Marina Noordzij; Matthijs Moerland; Cornelis Kluft; Adam F Cohen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-02       Impact factor: 2.745

10.  Improved hepatic arterial fraction estimation using cardiac output correction of arterial input functions for liver DCE MRI.

Authors:  Manil D Chouhan; Alan Bainbridge; David Atkinson; Shonit Punwani; Rajeshwar P Mookerjee; Mark F Lythgoe; Stuart A Taylor
Journal:  Phys Med Biol       Date:  2016-12-21       Impact factor: 3.609

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.